Enzybiotics LYSSTAPH-S and LYSDERM-S as Potential Therapeutic Agents for Chronic MRSA Wound Infections

0531787 - ÚIACH 2021 RIV CH eng J - Journal Article
Vacek, L. - Kobzová, Š. - Čmelík, Richard - Pantůček, R. - Janda, L.
Enzybiotics LYSSTAPH-S and LYSDERM-S as Potential Therapeutic Agents for Chronic MRSA Wound Infections.
Antibiotics (Basel). Roč. 9, č. 8 (2020), č. článku 519. ISSN 2079-6382. E-ISSN 2079-6382
Institutional support: RVO:68081715
Keywords : enzyme therapy * enzybiotics * lysostaphin
OECD category: Analytical chemistry
Impact factor: 4.639, year: 2020
Method of publishing: Limited access

Antistaphylococcal enzymes derived from lysostaphin and endolysin were modified in order to improve their antimicrobial properties and stability. These antimicrobial enzymes proved to be efficient in killing of the diverse strains of methicillin-resistant Staphylococcus aureus.
Permanent Link: http://hdl.handle.net/11104/0310404